Yasumasa Iwatani

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Antiretroviral Therapy

Hepatitis C Virus

Respiratory Syndrome Coronavirus

Top Venues

Nature communications

Nucleic acids research

Scientific reports

Journal of virology

This page only lists publications with an associated author ORCID identifier.

Publications

Hirotaka Ode, Masakazu Matsuda, Urara Shigemi, Mikiko Mori, Yoshimi Yamamura, Yoshihiro Nakata, Reiko Okazaki, Mai Kubota, Yuka Setoyama, Mayumi Imahashi, Yoshiyuki Yokomaku, Yasumasa Iwatani
Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations. Scientific reports 14 (1) (2024)
Hirotaka Ode, Masakazu Matsuda, Urara Shigemi, Mikiko Mori, Yoshimi Yamamura, Yoshihiro Nakata, Reiko Okazaki, Mai Kubota, Yuka Setoyama, Mayumi Imahashi, Yoshiyuki Yokomaku, Yasumasa Iwatani
Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations. Scientific reports 14 (1) (2024)
Hirotaka Ode, Masakazu Matsuda, Urara Shigemi, Mikiko Mori, Yoshimi Yamamura, Yoshihiro Nakata, Reiko Okazaki, Mai Kubota, Yuka Setoyama, Mayumi Imahashi, Yoshiyuki Yokomaku, Yasumasa Iwatani
Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations. Scientific reports 14 (1) (2024)
Mai Komori, Takuto Nogimori, Amber L Morey, Takashi Sekida, Keiko Ishimoto, Matthew R Hassett, Yuji Masuta, Hirotaka Ode, Tomokazu Tamura, Rigel Suzuki, Jeff Alexander, Yasutoshi Kido, Kenta Matsuda, Takasuke Fukuhara, Yasumasa Iwatani, Takuya Yamamoto, Jonathan F Smith, Wataru Akahata
saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern. Nature communications 14 (1) (2023)
Yoshihiro Nakata, Hirotaka Ode, Mai Kubota, Takaaki Kasahara, Kazuhiro Matsuoka, Atsuko Sugimoto, Mayumi Imahashi, Yoshiyuki Yokomaku, Yasumasa Iwatani
Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome. Nucleic acids research 51 (2) (2023)
Yoshihiro Nakata, Hirotaka Ode, Mai Kubota, Takaaki Kasahara, Kazuhiro Matsuoka, Atsuko Sugimoto, Mayumi Imahashi, Yoshiyuki Yokomaku, Yasumasa Iwatani
Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome. Nucleic acids research 51 (2) (2023)
Mai Komori, Takuto Nogimori, Amber L Morey, Takashi Sekida, Keiko Ishimoto, Matthew R Hassett, Yuji Masuta, Hirotaka Ode, Tomokazu Tamura, Rigel Suzuki, Jeff Alexander, Yasutoshi Kido, Kenta Matsuda, Takasuke Fukuhara, Yasumasa Iwatani, Takuya Yamamoto, Jonathan F Smith, Wataru Akahata
saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern. Nature communications 14 (1) (2023)
Atsuko Sugimoto, Takahiro Watanabe, Kazuhiro Matsuoka, Yusuke Okuno, Yusuke Yanagi, Yohei Narita, Seiyo Mabuchi, Hiroyuki Nobusue, Eiji Sugihara, Masaya Hirayama, Tomihiko Ide, Takanori Onouchi, Yoshitaka Sato, Teru Kanda, Hideyuki Saya, Yasumasa Iwatani, Hiroshi Kimura, Takayuki Murata
Growth Transformation of B Cells by Epstein-Barr Virus Requires IMPDH2 Induction and Nucleolar Hypertrophy. Microbiology spectrum (2023)
Shunsuke Uno, Hiroyuki Gatanaga, Tsunefusa Hayashida, Mayumi Imahashi, Rumi Minami, Michiko Koga, Sei Samukawa, Dai Watanabe, Teruhisa Fujii, Masao Tateyama, Hideta Nakamura, Shuzo Matsushita, Yusuke Yoshino, Tomoyuki Endo, Masahide Horiba, Toshibumi Taniguchi, Hiroshi Moro, Hidetoshi Igari, Shigeru Yoshida, Takanori Teshima, Hideaki Nakajima, Masako Nishizawa, Yoshiyuki Yokomaku, Yasumasa Iwatani, Atsuko Hachiya, Shingo Kato, Naoki Hasegawa, Kazuhisa Yoshimura, Wataru Sugiura, Tadashi Kikuchi
Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study. The Journal of antimicrobial chemotherapy (2023)
Mai Komori, Takuto Nogimori, Amber L Morey, Takashi Sekida, Keiko Ishimoto, Matthew R Hassett, Yuji Masuta, Hirotaka Ode, Tomokazu Tamura, Rigel Suzuki, Jeff Alexander, Yasutoshi Kido, Kenta Matsuda, Takasuke Fukuhara, Yasumasa Iwatani, Takuya Yamamoto, Jonathan F Smith, Wataru Akahata
saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern. Nature communications 14 (1) (2023)
Yoshihiro Nakata, Hirotaka Ode, Mai Kubota, Takaaki Kasahara, Kazuhiro Matsuoka, Atsuko Sugimoto, Mayumi Imahashi, Yoshiyuki Yokomaku, Yasumasa Iwatani
Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome. Nucleic acids research 51 (2) (2023)
Yoshihiro Nakata, Hirotaka Ode, Mai Kubota, Takaaki Kasahara, Kazuhiro Matsuoka, Atsuko Sugimoto, Mayumi Imahashi, Yoshiyuki Yokomaku, Yasumasa Iwatani
Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome. Nucleic acids research (2023)
Mikiko Mori, Hirotaka Ode, Mai Kubota, Yoshihiro Nakata, Takaaki Kasahara, Urara Shigemi, Reiko Okazaki, Masakazu Matsuda, Kazuhiro Matsuoka, Atsuko Sugimoto, Atsuko Hachiya, Mayumi Imahashi, Yoshiyuki Yokomaku, Yasumasa Iwatani
Nanopore Sequencing for Characterization of HIV-1 Recombinant Forms. Microbiology spectrum 10 (4) (2022)
Taishi Kondo, Kazuhiro Matsuoka, Shun Umemoto, Tomoshige Fujino, Gosuke Hayashi, Yasumasa Iwatani, Hiroshi Murakami
Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern. Life science alliance 5 (6) (2022)
Toong Seng Tan, Mako Toyoda, Hirotaka Ode, Godfrey Barabona, Hiroshi Hamana, Mizuki Kitamatsu, Hiroyuki Kishi, Chihiro Motozono, Yasumasa Iwatani, Takamasa Ueno
Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike. Journal of virology 96 (20) (2022)
Hirotaka Ode, Yoshihiro Nakata, Mami Nagashima, Masaki Hayashi, Takako Yamazaki, Hiroyuki Asakura, Jun Suzuki, Mai Kubota, Kazuhiro Matsuoka, Masakazu Matsuda, Mikiko Mori, Atsuko Sugimoto, Mayumi Imahashi, Yoshiyuki Yokomaku, Kenji Sadamasu, Yasumasa Iwatani
Molecular epidemiological features of SARS-CoV-2 in Japan, 2020-1. Virus evolution 8 (1) (2022)
Toong Seng Tan, Mako Toyoda, Hirotaka Ode, Godfrey Barabona, Hiroshi Hamana, Mizuki Kitamatsu, Hiroyuki Kishi, Chihiro Motozono, Yasumasa Iwatani, Takamasa Ueno
Erratum for Tan et al., "Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike". Journal of virology (2022)
Takaaki Kasahara, Mayumi Imahashi, Chieko Hashiba, Mikiko Mori, Ayumi Kogure, Yoshiyuki Yokomaku, Naozumi Hashimoto, Yasumasa Iwatani, Yoshinori Hasegawa
Retrospective Analysis of the Efficacy of Early Antiretroviral Therapy in HIV-1-Infected Patients Coinfected with Pneumocystis jirovecii. AIDS research and human retroviruses 37 (10) (2021)
Seiya Ozono, Yanzhao Zhang, Hirotaka Ode, Kaori Sano, Toong Seng Tan, Kazuo Imai, Kazuyasu Miyoshi, Satoshi Kishigami, Takamasa Ueno, Yasumasa Iwatani, Tadaki Suzuki, Kenzo Tokunaga
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity. Nature communications 12 (1) (2021)
Noboru Urata, Tsunamasa Watanabe, Noboru Hirashima, Yoshiyuki Yokomaku, Junji Imamura, Yasumasa Iwatani, Masaaki Shimada, Yasuhito Tanaka
Cytokines and Chemokines Involved in Hepatitis B Surface Antigen Loss in Human Immunodeficiency Virus/Hepatitis B Virus Coinfected Patients. Journal of clinical medicine 10 (4) (2021)
Atsuko Sugimoto, Yuichi Abe, Tadashi Watanabe, Kohei Hosokawa, Jun Adachi, Takeshi Tomonaga, Yasumasa Iwatani, Takayuki Murata, Masahiro Fujimuro
The FAT10 post-translational modification is involved in the lytic replication of Kaposi's sarcoma-associated herpesvirus. Journal of virology (2021)